SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: LemonHead who wrote (1132)8/10/1998 11:37:00 AM
From: Zvi Steinberg  Read Replies (1) | Respond to of 1491
 
Pharmos (and more) in Globes:

globes.co.il



To: LemonHead who wrote (1132)8/10/1998 12:29:00 PM
From: Filbert  Respond to of 1491
 
>> Filbert, could you explain this statement further?

**so please no flames about me being "short".** <<

Sometimes when one posts on these threads something that is not popular with the overall tone of the thread, some people attempt to debate the issue by emotionally confronting the poster as trying to "short" the stock and to drive the price down by posting negative information. I wasn't actually too worried about this thread. The people on this thread are usually quite balanced in their postings and analysis.

Secondly, to yosi and ariella, if you want to discuss the matter further why don't we use P-mail. I wasn't trying to be negative, just cautious. I don't know the reaction pathway or the purification pathway to HU-211 so I can't claim anything for sure. But the batch size required for a clinical, even a Phase III clinical, is much smaller than a production lot. I believe that HU-211 will be successful and launch first, but sometimes things happen. Lotemax and Alrex launched a little later than originally planned for instance.

Good luck to all,

Filbert